Related content

Metformin and FSH for induction of ovulation in women with polycystic ovarian syndrome

By De Leo Vincenzo   la Marca Antonio  

Human Reproduction, Vol. 17, Iss. 9, 2002-09 ,pp. : 2481-2482

Oxford University Press

Access to resources Recommend Favorite

Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome

By Nascimento Areana Diogo   Lara Lucia Alves Silva   Rosa-e-Silva Ana Carolina Japur de Sá   Ferriani Rui Alberto   Reis Rosana Maria  

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 246-249

Informa Healthcare

Access to resources Recommend Favorite

Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy

By Berker B   Emral R   Demirel C   Corapcioglu D   Unlu C   Kose K  

Gynecological Endocrinology, Vol. 19, Iss. 3, 2004-09 ,pp. : 125-133

Informa Healthcare

Access to resources Recommend Favorite

Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?

By Cibula D.  

Human Reproduction, Vol. 16, Iss. 5, 2001-05 ,pp. : 940-944

Oxford University Press

Access to resources Recommend Favorite

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol–cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

By Elter Koray   Imir Gonca   Durmusoglu Fatih  

Human Reproduction, Vol. 17, Iss. 7, 2002-07 ,pp. : 1729-1737

Oxford University Press

Access to resources Recommend Favorite